News

Published on 27 Mar 2022 on Motley Fool

Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.


Article preview image

When most of us think of coronavirus programs, we probably think of Moderna (NASDAQ: MRNA) or Pfizer...

NASDAQ.SRNE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is a Surprise Coming for Sorrento Therapeutics (SRNEQ) This Earnings Season?

Investors are always looking for stocks that are poised to beat at earnings season and Sorrento T...

Zacks via Yahoo Finance 2 Mar 2023

Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing

Sorrento Therapeutics Inc (NASDAQ: SRNE) announced that the U.S. Bankruptcy Court for the Souther...

Benzinga via Yahoo Finance 22 Feb 2023

An Update On Sorrento: Hitting Rock Bottom And Finding A Shovel (NASDAQ:SCLX)

One should note that Sorrento Therapeutics has been involved in multiple legal actions with Dr....

Seeking Alpha 22 Feb 2023

Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's...

Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's...

Investing.com 13 Feb 2023

Sorrento Therapeutics Stock Nosedives After Filing Bankruptcy Paperwork

COVID-19 drug and vaccine developer Sorrento Therapeutics Inc (NASDAQ: SRNE) is filing for bankru...

Benzinga via Yahoo Finance 13 Feb 2023

Sorrento Therapeutics Files for Bankruptcy to Halt $173 Million Licensing Judgments

The biopharmaceutical company filed for chapter 11 to halt the collection of judgments by affilia...

The Wall Street Journal 13 Feb 2023

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%

Investing.com 13 Feb 2023

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%

U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.11%

Investing.com 13 Feb 2023

ImmunityBio: Upcoming PDUFA, Solid Data, Confusing Finances (NASDAQ:IBRX)

ImmunityBio, Inc. (NASDAQ:IBRX) is another Patrick Soon-Shiong company, one of the relatively mor...

Seeking Alpha 6 Jan 2023

Sorrento Touts Positive Early-Stage Trial Data From Oral COVID-19 Therapy

Sorrento Therapeutics Inc (NASDAQ: SRNE) released topline Phase 2 SAD/MAD study data of its oral ...

Benzinga via Yahoo Finance 30 Nov 2022